FCS Physicians, Clinicians and Leaders Share Innovations in Cancer Care At Patient-Centered Oncology Care® Conference

Fort Myers, Fla., September 11, 2024  —  Florida Cancer Specialists & Research Institute, LLC (FCS) physicians, clinicians and leaders will participate as expert panelists at the Patient-Centered Oncology Care® (PCOC) conference presented by The American Journal of Managed Care® (AJMC) this week in Nashville. The theme, Innovations in Cancer Care: Tales from the Front Line, sets the stage for discussions around relevant issues in the delivery of cancer care in community settings.

“Amidst a constantly evolving landscape, our patients remain at the center of all that we do,” said FCS President and Managing Physician Lucio N. Gordan, MD. “We welcome this opportunity to join with our colleagues — providers, payers and leaders, to advance solutions that will enhance the lives of our patients throughout their cancer journey.”

FCS participants in panel discussions are:

• Gustavo Fonseca, MD, FACP, medical oncologist and hematologist, and Paul Chadwick, chief value and procurement officer: “New Faces at the Table: How to Keep Your Clinical Pathways Discussions Fresh.”
• Maen Hussein, MD, medical oncologist and hematologist, Josh Eaves, chief development and strategy officer, and Kiana Mehring, MBA, senior director of strategic partnerships, managed care: “FCS Network Panel. “
• Christopher Elder, PharmD, BCOP, associate director of pharmacy clinical services: “The Increased Visibility of Pharmacy in Cancer Care Decisions.”

Nathan H. Walcker, FCS chief executive officer, noted, “As the leading provider of community-based cancer care across Florida for more than 40 years, FCS is deeply committed to sharing initiatives that deliver maximum value and effectiveness in reducing healthcare costs and improving patient outcomes.”

FCS is dedicated to delivering value to its patients and has been a known leader in the value-based care space taking into consideration every aspect of the patient’s journey. Through its in-house next-generation sequencing capabilities, precision oncology applications, holistic model of care application and care coordination offerings, patients are receiving optimal, personalized care at every step.